The technology used by Dr. Moro indeed works and I now know a lot more about the technology than I did a year ago. By this time next year, RECAF tests will be at or near completion in trials. There are not really any more obstacles holding them back.
The fact that Abbott has not progressed as rapidly as initially expected is now hurting the investor confidence. It has been 27 months and that is really a shame. That will be rectified when new partners are signed and they in fact may beat Abbott to market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.